Single-Agent Brentuximab as Bridging Therapy for Hodgkin Lymphoma Patients with Hepatic Impairment

Arjun Gupta; Jan Petrasek; Shiraj Sen; Purva Gopal; Harris V. Naina

doi:10.1016/j.clml.2015.11.015

Single-Agent Brentuximab as Bridging Therapy for Hodgkin Lymphoma Patients with Hepatic Impairment

Arjun Gupta
, Jan Petrasek
, Shiraj Sen
, Purva Gopal
, Harris V. Naina

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	e11-e14
Journal	Clinical Lymphoma, Myeloma and Leukemia
Volume	16
Issue number	2
DOIs	https://doi.org/10.1016/j.clml.2015.11.015
State	Published - Feb 1 2016
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Anti CD-30
Chemotherapy
Hepatic impairment
Liver failure
Lymphoma

Publisher link

10.1016/j.clml.2015.11.015

Find It

Find It at U of M Libraries

Cite this

@article{6a1f0d1d42cd47e2b35c8ac384d0c7a3,

title = "Single-Agent Brentuximab as Bridging Therapy for Hodgkin Lymphoma Patients with Hepatic Impairment",

keywords = "Anti CD-30, Chemotherapy, Hepatic impairment, Liver failure, Lymphoma",

author = "Arjun Gupta and Jan Petrasek and Shiraj Sen and Purva Gopal and Naina, \{Harris V.\}",

year = "2016",

month = feb,

day = "1",

doi = "10.1016/j.clml.2015.11.015",

language = "English (US)",

volume = "16",

pages = "e11--e14",

journal = "Clinical Lymphoma, Myeloma and Leukemia",

issn = "2152-2650",

publisher = "Elsevier Inc.",

number = "2",

}

TY - JOUR

T1 - Single-Agent Brentuximab as Bridging Therapy for Hodgkin Lymphoma Patients with Hepatic Impairment

AU - Gupta, Arjun

AU - Petrasek, Jan

AU - Sen, Shiraj

AU - Gopal, Purva

AU - Naina, Harris V.

PY - 2016/2/1

Y1 - 2016/2/1

KW - Anti CD-30

KW - Chemotherapy

KW - Hepatic impairment

KW - Liver failure

KW - Lymphoma

UR - https://www.scopus.com/pages/publications/84957838963

UR - https://www.scopus.com/pages/publications/84957838963#tab=citedBy

U2 - 10.1016/j.clml.2015.11.015

DO - 10.1016/j.clml.2015.11.015

M3 - Article

C2 - 26775723

AN - SCOPUS:84957838963

SN - 2152-2650

VL - 16

SP - e11-e14

JO - Clinical Lymphoma, Myeloma and Leukemia

JF - Clinical Lymphoma, Myeloma and Leukemia

IS - 2

ER -

Single-Agent Brentuximab as Bridging Therapy for Hodgkin Lymphoma Patients with Hepatic Impairment

UN SDGs

Keywords

Publisher link

Find It

Other files and links

Cite this